Aleafia Health Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.19% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.01
| Current Ratio | 1.01 |
| Quick Ratio | 0.13 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.03 |
| Interest Coverage | -1.90 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -15.69% |
| Return on Invested Capital (ROIC) | -23.38% |
| Return on Capital Employed (ROCE) | -73.12% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 200,430 |
| Profits Per Employee | -161,885 |
| Employee Count | 158 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.93 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 1.75 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 47.11 |
| Average Volume (20 Days) | 54,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aleafia Health had revenue of 31.67 million and -25.58 million in losses. Loss per share was -0.07.
| Revenue | 31.67M |
| Gross Profit | 4.43M |
| Operating Income | -13.12M |
| Pretax Income | -25.58M |
| Net Income | -25.58M |
| EBITDA | -8.71M |
| EBIT | -13.12M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 395,415 in cash and 34.25 million in debt, with a net cash position of -33.85 million.
| Cash & Cash Equivalents | 395,415 |
| Total Debt | 34.25M |
| Net Cash | -33.85M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -6.59M |
| Book Value Per Share | -0.02 |
| Working Capital | 152,992 |
Cash Flow
In the last 12 months, operating cash flow was -2.57 million and capital expenditures -1.22 million, giving a free cash flow of -3.79 million.
| Operating Cash Flow | -2.57M |
| Capital Expenditures | -1.22M |
| Free Cash Flow | -3.79M |
| FCF Per Share | n/a |
Margins
Gross margin is 14.00%, with operating and profit margins of -41.44% and -80.77%.
| Gross Margin | 14.00% |
| Operating Margin | -41.44% |
| Pretax Margin | -80.77% |
| Profit Margin | -80.77% |
| EBITDA Margin | -27.49% |
| EBIT Margin | -41.44% |
| FCF Margin | n/a |
Dividends & Yields
Aleafia Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.15% |
| Shareholder Yield | -18.15% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aleafia Health has an Altman Z-Score of -12.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.35 |
| Piotroski F-Score | 3 |